| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |